Understanding tuberculosis transmission and progression: A prospective cohort study of index cases and close contacts

Rehan R Syed1, Donald G Catanzaro2, Naomi Hillery3

  • 1Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.

Plos One
|December 5, 2024
PubMed
Abstract

Insights

Tuberculosis (TB) progression occurred in 2.3% of close contacts, with male sex, tobacco use, and prolonged exposure being key risk factors. Enhanced monitoring and diagnostics are crucial for managing TB transmission in high-risk populations.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) remains a global health challenge, particularly in low-burden countries with high rates of drug-resistant strains.
  • Close contacts of individuals with active TB are at an elevated risk of developing the disease.
  • Understanding TB progression dynamics in high-risk groups is essential for effective control strategies.

Purpose of the Study:

  • To determine the incidence rate, risk factors, and timeline of progression from TB exposure to active disease among close contacts.
  • To investigate TB disease progression in a prospective cohort within the Republic of Moldova, a low-burden country with significant drug-resistant TB.
  • To identify specific risk factors associated with increased likelihood of TB progression in this population.

Main Methods:

  • Prospective cohort study involving close contacts of newly diagnosed TB patients.
  • Regular clinical evaluations and sample collection over a minimum of 24 months.
  • Data collection included demographics, medical history, exposure details, and clinical assessments.

Main Results:

  • The overall incidence of TB disease among close contacts was 3.7%.
  • Progressor cases (TB diagnosed >30 days after index case treatment) accounted for 2.3% of contacts.
  • Significant risk factors for progression included male sex, active tobacco use, prior TB infection, and prolonged daily exposure (>8 hours) to index cases (adjusted OR: 4.28).

Conclusions:

  • The observed TB incidence in close contacts aligns with global data, emphasizing the need for improved diagnostics and interventions.
  • Contact tracing and monitoring for progression are vital in settings with low TB incidence but high drug resistance.
  • Further research is recommended to elucidate risk factors and develop biomarkers for identifying individuals at highest risk of TB progression.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
303
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K